Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell State Street SPDR S&P Biotech ETF (XBI) – State Street SPDR S&P Biotech ETF Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

XBI, the SPDR S&P Biotech ETF, trades at $131.16, down 1.59% on the day. Technical indicators show a bullish trend with moving averages supporting upside, while oscillators are neutral. The ETF has seen significant institutional buying interest recently, with multiple firms increasing stakes. Biotech sector performance has been strong, with gains around 35% over the past year according to 24/7 Wall Street on March 31, 2026.
The outlook for XBI appears cautiously optimistic given sector momentum and institutional accumulation, though valuation concerns and mixed technical signals present near-term risks. Higher interest rates and market risk appetite remain key watchpoints for biotech ETFs.
Read full analysis

Key Stats

  • Market Cap
    -
  • Sector
    Broad Market / Factor
  • 3M Drawdown
    -8.04%
  • Enterprise Value
    -
  • Dividend Yield
    -
  • Trading Activity
    3% Buy | 97% Sell
  • Typical Hold Time
    16 days
$131.15
52W Low: $76.37
14 May 2025
52W High: $138.67
17 Apr 2026

Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $76.37 and a high of $138.67, highlighting its annual price range. Over the past three months, State Street SPDR S&P Biotech ETF has recorded a drawdown of -8.04%, reflecting recent price volatility. On average, investors hold State Street SPDR S&P Biotech ETF for approximately 16 days, indicating typical investor behavior on the platform.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.


Technical Indicators
|
|
|
Overall Summary
Bearish (15)Neutral (10)Bullish (2)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    -
  • Sector
    Broad Market / Factor
  • 3M Drawdown
    -8.04%
  • Enterprise Value
    -
  • Dividend Yield
    -
  • Trading Activity
    3% Buy | 97% Sell
  • Typical Hold Time
    16 days
$131.15
52W Low: $76.37
14 May 2025
52W High: $138.67
17 Apr 2026

Over the past 52 weeks, State Street SPDR S&P Biotech ETF has traded between a low of $76.37 and a high of $138.67, highlighting its annual price range. Over the past three months, State Street SPDR S&P Biotech ETF has recorded a drawdown of -8.04%, reflecting recent price volatility. On average, investors hold State Street SPDR S&P Biotech ETF for approximately 16 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!